Results for “NHS”

NHS Blood and Transplant (NHSBT) is procuring delivery partners for the Donor and Session Programme (DASP), a strategic digital transformation programme to modernise donor engagement, appointment booking, session management and related donor-facing and operational capabilities across blood, platelets and plasma. The procurement is divided into two Lots: Lot 1: Technical Implementation Partner The Technical Implementation Partner will support the technical implementation of the selected CRM Platform and associated digital ecosystem. The scope includes solution design, configuration, integration, data migration, testing, deployment, transition, implementation governance, technical assurance and operational readiness. Suppliers tendering for Lot 1 must align their Tender Response to one of the eligible CRM Platforms identified in the Invitation to Tender documents. The proposed technical solution, implementation approach and associated commercial submissions must be prepared consistently on the basis of the selected CRM Platform. Lot 2: Business Change Partner The Business Change Partner will support the business change, adoption and operational transformation required to implement DASP successfully. The scope includes operating model and workforce transformation, stakeholder engagement, change impact assessment, communications, learning and capability development, adoption planning, business readiness, benefits realisation and transition to business as usual. NHSBT intends to award a single-supplier contract for each Lot. Suppliers may tender for either Lot or both Lots but must submit a complete and independently compliant Tender Response for each Lot tendered for. The full requirements, eligible CRM Platforms, procurement procedure, Conditions of Participation, award criteria, evaluation methodology, timetable, contract terms and submission instructions are set out in the Invitation to Tender and associated tender documents available through Atamis under reference C468497.

Gloucestershire ICB and Bristol, North Somerset and South Gloucestershire (BNSSG) ICB are merging to form a single integrated body in April 2027. Both organisations currently rely on external providers for the delivery of their IT services. A new, unified service model is required; one that supports the merged organisation from day one, is commercially sustainable, and is capable of evolving as the ICS matures. Six principles shape the design of the future service: 1. Cloud-first and 'secure by design'. All new and renewed services will be cloud-based wherever possible. On-premises infrastructure will be exited as part of transition. This is both a strategic choice and a compliance requirement under the Government Cloud First Policy and Technology Code of Practice. 2. Outcome-focused. The service is defined by what it must deliver, not how it must be delivered. The supplier is expected to bring expertise, innovation and accountability for outcomes, not simply execute a prescriptive technical specification. 3. Single point of accountability. The preferred model is a single managed service provider with end-to-end accountability for operational delivery. This avoids the fragmentation and unclear ownership that characterises the current multi-supplier landscape and reduces the management overhead on the ICB digital team. 4. Lean governance. The ICB digital team will provide strategic oversight, roadmap ownership and supplier governance. It will not carry operational delivery responsibilities. This reflects the lean, strategically focused character of the merged organisation and the direction set by the Model ICB Blueprint. 5. Interoperable by design. The service must integrate cleanly with nationally contracted NHS platforms, in particular NHS.net Connect, the Health and Social Care Network (HSCN) and NHS Secure Boundary Service, as well as local platforms, such as the Gloucestershire ICS WAN and into UHBW and Crown Datacentres in Corsham. Service interfaces with these platforms should be clearly defined before the procurement specification is finalised. 6. Sustainable. The ICB's carbon neutral commitments should be reflected in technology choices, including energy-efficient end-user devices, PoE-powered monitors and cloud-based infrastructure in preference to on-premises data centre equipment. The following service stacks are in scope for the new managed service, reflecting services currently provided across both incumbents, consolidated and extended to support the merged organisation: - Service desk. The primary user-facing support channel, available 08:00-18:00 Monday to Friday. - Desktop support. Onsite presence at both sites as and when required, including end-user support, moves, adds and changes to desktop arrangements, MFD, Audio Visual equipment, and Teams Room management. The onsite support model must include provision for routine physical tasks including WFH equipment management, peripheral replacement, cable and hardware swap-outs, and stock management. - End-user compute. Device lifecycle management including provisioning, refresh (five-year target cycle), configuration, and secure disposal. - Telephony and unified communications. Microsoft Teams Phone as the unified platform for the merged ICB. - Print. Cloud-managed secure print at both sites. - Meeting rooms. Physical teams Room management and audio-visual support at 2 locations with 15 meeting rooms at one and at Shire Hall, Gloucester and 9 at the second location. - Asset management. Asset tagging, recording, and lifecycle tracking for all ICB-owned IT equipment. - Supplier and procurement management. The supplier will assume management of all ongoing third-party technology relationships and will procure all IT equipment and recurring support contracts on behalf of the ICB. Licence management across the estate is required. - DSPT support. The supplier is expected to provide the ICB with the technical evidence and assurance data required to support annual DSPT submission, including patch management records, asset inventory, access control logs and incident reports. - Project, change and architecture. The supplier will own project and change management, problem management, and architecture design. - Digital signatures. Digital signature capability is required as part of the new service. Full details are provided in the service specification. The total maximum contract value for the initial 3-year Contract is £1,920,000 inclusive of VAT (where applicable). At the end of the initial contract term the Commissioner will have two, separate, consecutive one-year extension option periods that can be exercised at the discretion of the Commissioner, giving a maximum possible contract value of £2,700,000 inclusive of VAT (where applicable) over 5 years if the full contract term is fulfilled. The Commissioner is of the view that TUPE does not apply to this service. The Contracting Authority reserves the right to use the Direct Award procedure under the Procurement Act 2023 for any subsequent extensions or new contracts for similar requirements. The new contract will commence on 1st April 2027, although implementation of the services will start during January 2027.

Tender to undertake building works to remodel existing estate to provide a new Mental Health ED department.

This project aims to procure a HTP DNA extraction solution, ensuring continuity and scalability of DNA-based diagnostic services

NHS Blood and Transplant (NHSBT) is a Special Health Authority in England, with responsibilities across the United Kingdom for organ donation and transplantation. Our core purpose is to ‘save and improve lives’ through the provision of a safe and reliable supply of blood components, solid organs, stem cells, tissues and related services to the NHS, and to the other UK Health Services where directed.  Testing function in the Blood Supply Directorate performs a wide range of testing services, these include but are not limited to the large-scale blood grouping and microbiological screening of blood and tissue donations. The Authority has two testing sites in England, in which approximately 1.5 million donations are tested each year. Each donation bled requires a minimum of 3 x 6mL sample tubes to be taken into K2 EDTA tubes which have colour coded caps for identification purposes. Some donors also require additional tubes these include but are not limited to 4mL EDTA and K3 EDTA tubes. Tubes are of the evacuation type and the Authority requires a unique bar-code label to be affixed at bed side over a blank manufacturers label.

The development of a specialist all age mental health response via 111 is a key ambition of the NHS England Long Term Plan (2021-2024), and the recovery plan for urgent and emergency care priority for 2023/24. This required all calls for support during mental health crisis to be made via 111 by the end of March 2024 and is referred to as 111-2. Avon and Wiltshire Mental Health Partnership NHS Trust (AWP) currently deliver this service in partnership with a system partner. AWP will shortly be seeking a provider to deliver an integrated model for the NHS 111 Mental Health Crisis Response Service (111 Option 2) for individuals experiencing a mental health crisis across both adult (18 years and over) and children and young people (under 18 years) pathways. The appointed provider will be solely responsible for the delivery of the call handling element of the 111 Option 2 pathway, including access, triage and call management. AWP will retain responsibility for all clinical assessment activity and associated clinical decision-making and outcomes. The provider must be able to operate within a matrix management model, whereby all partners maintain responsibility for their own governance arrangements, professional standards and areas of specialist expertise, while working collaboratively at both strategic and operational leadership levels to deliver a seamless, integrated and high-quality service. The service forms part of the NHS England requirement that callers contacting NHS 111 and selecting the mental health option are connected directly to a dedicated mental health response service available 24 hours per day, 7 days per week. The service will work collaboratively with urgent and emergency care pathways, crisis services, community mental health teams, acute hospitals, ambulance services, primary care and voluntary sector partners. AWP are seeking to understand what interest there might be from providers and the barriers that may exist in providing these services. All documents or information provided as part of this engagement exercise are in draft form only. The Commissioner reserves the right to amend or change any of the content. Interested parties should note that a response to this Notice does not guarantee an automatic invitation to any subsequent formal process, which the Commissioner will consider in due course. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18282. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18282 as the reason for registration. Any queries please contact MultiQuote on 020 3920 8054.

Supply and installation of Fire Compartmentation works to communal areas of multi-storey high rise residential building located within the Poole General Hospital campus

Renovation of Block 14 into an Antenatal ward/department at Musgrove Park Hospital.

This opportunity is being run under the Provider Selection Regime (PSR) regulations. The development of a specialist all age mental health response via 111 is a key ambition of the NHS England Long Term Plan (2021-2024), and the recovery plan for urgent and emergency care priority for 2023/24. This required all calls for support during mental health crisis to be made via 111 by the end of March 2024 and is referred to as 111-2. Avon and Wiltshire Mental Health Partnership NHS Trust (AWP) currently deliver this service in partnership with a system partner. AWP is seeking a provider to deliver an integrated model for the NHS 111 Mental Health Crisis Response Service (111 Option 2) for individuals experiencing a mental health crisis across both adult (18 years and over) and children and young people (under 18 years) pathways. The appointed provider will be solely responsible for the delivery of the call handling element of the 111 Option 2 pathway, including access, triage and call management. AWP will retain responsibility for all clinical assessment activity and associated clinical decision-making and outcomes. The provider must be able to operate within a matrix management model, whereby all partners maintain responsibility for their own governance arrangements, professional standards and areas of specialist expertise, while working collaboratively at both strategic and operational leadership levels to deliver a seamless, integrated and high-quality service. The service forms part of the NHS England requirement that callers contacting NHS 111 and selecting the mental health option are connected directly to a dedicated mental health response service available 24 hours per day, 7 days per week. The service will work collaboratively with urgent and emergency care pathways, crisis services, community mental health teams, acute hospitals, ambulance services, primary care and voluntary sector partners. To access this competition: Registered: Login to https://suppliers.multiquote.com and view the opportunity CA18282. Not registered: Visit https://suppliers.multiquote.com then register and quote CA18282 as the reason for registration.

Gloucestershire Health and Care NHS Foundation Trust ("the Authority") is seeking to appoint a suitably qualified and experienced provider for the delivery of Physical Pharmacy Services across its Physical Health services within Gloucestershire. The Authority delivers a diverse range of community-based, outpatient, rehabilitation, intermediate care, and inpatient physical healthcare services. The successful contractor will be required to provide a comprehensive, safe, effective, and patient-centred pharmacy service that supports the delivery of high-quality clinical care, medicines optimisation, and statutory compliance across the Trust's physical health portfolio. The service will be expected to provide expert pharmacy support, including but not limited to medicines management, medicines optimisation, clinical pharmacy input, governance and assurance activities, medicines reconciliation, prescribing support, staff training and education, audit and quality improvement activities, and specialist pharmaceutical advice to multidisciplinary teams. The Authority is seeking a provider that can demonstrate: Extensive experience in delivering pharmacy services within NHS and/or comparable healthcare environments; Strong clinical governance and medicines safety arrangements; - A skilled and resilient workforce capable of supporting services across multiple care settings; - The ability to work collaboratively with clinical teams and system partners; - Innovative approaches to medicines optimisation and service improvement; - Robust digital capabilities, reporting arrangements, and data management processes; and - A commitment to delivering high-quality patient outcomes, value for money, sustainability, and social value. The contract will support the Authority's strategic objectives by ensuring that patients receive safe, effective, and timely pharmaceutical care, while promoting the appropriate use of medicines and supporting service efficiency across physical healthcare pathways. The procurement will be conducted through an open and transparent competitive process. Tender submissions will be evaluated on the basis of the Most Advantageous Tender (MAT), taking into account quality, service delivery, clinical governance, social value, and commercial considerations. Full details of the evaluation methodology and award criteria will be provided within the procurement documentation. The successful provider will be expected to mobilise and maintain a service model that is responsive to changing patient needs, workforce challenges, regulatory requirements, and developments in pharmacy practice throughout the contract term. Further information relating to the scope of services, contract requirements, performance standards, Key Performance Indicators (KPIs), and contractual arrangements will be included within the Invitation to Tender documentation. Registration and documentation will be available for suppliers on Monday 21st September 2026.

The South Western Ambulance Service NHS Foundation Trust, acting on behalf of the Southern Ambulance Services Collaborative (SASC), is seeking to establish a single-supplier Closed Framework Agreement for the supply and delivery of ambulance workshop consumables and associated goods to support the maintenance, repair and operational readiness of ambulance fleet vehicles across participating NHS ambulance trusts. The framework is intended for use by South Western Ambulance Service NHS Foundation Trust (SWAST), South East Coast Ambulance Service NHS Foundation Trust (SECAmb), London Ambulance Service NHS Trust (LAS), East of England Ambulance Service NHS Trust (EEAST) and South Central Ambulance Service NHS Foundation Trust (SCAS). The framework will cover a broad range of workshop consumables and associated products including, but not limited to: Workshop chemicals, cleaners, degreasers and maintenance products, ect.

A three year contract for the coaching and development of the executive and senior team to support a wider business transformation programme. NHSBT will be looking for proven experience of supporting business transformation and supporting a senior executive team.

Procurement of a framework solution for both clinical and non-clinical apprenticeships and education related services. The offering will be provided via a three-way collaboration with Salisbury NHS Foundation Trust, North of England Commercial Procurement Collaborative (NOE CPC) and London Procurement Partnership (NHS LPP).

Bristol NHS Foundation Trust (BFT) intends to commence a procurement exercise, potential as early as November 2026, to secure a provider capable of delivering the provision of a fully managed Lung Cancer Screening (LCS) service, previously known as the Targeted Lung Health (TLHC), across the Somerset, Wiltshire, Avon and Gloucestershire (SWAG) regional programme. The proposed contract term is anticipated to be 36 months, with the option to extend for up to two further periods of 12 months each, resulting in a maximum potential contract duration of 60 months. The procurement is expected to establish an end-to-end managed service, with the appointed provider responsible for the delivery of services including, but not limited to: • Clinical and diagnostic services, including the provision of appropriately qualified workforce and equipped mobile units. • IT systems and data management services. • Programme management services, including logistics, stakeholder communications, and continuous service development. Whilst the final service model remains subject to further development, the anticipated pathway is expected to include: 1. Identification of the eligible population cohort. 2. Appointment booking and scheduling. 3. Lung Health Check assessment. 4. Face-to-face clinical review and Low-Dose CT (LDCT) scanning. 5. Reporting and clinical assessment of results. 6. Multidisciplinary screening review meetings. 7. Communication of results, including rebooking where applicable; and 8. Follow-up, surveillance and recall activities. BFT is currently evaluating potential procurement routes under the Provider Selection Regime (PSR), including: • A Competitive Process conducted through the open market; or • A further competition via the NHS Shared Business Services (SBS) Clinical Managed Services Framework (SBS10251) BFT is seeking to implement the service within a challenging timeframe to support delivery of the SWAG Lung Cancer Screening Programme. Interested providers should note the anticipated accelerated procurement and mobilisation requirements and ensure they have sufficient capacity and resources to participate. The current indicative timetable is as follows: Tender Publication 02-Nov-26 Bid Submission Deadline 30-Nov-26 Contract Award 26-Jan-27 Contract Mobilisation 01-Feb-27 Service Commencement 01-Ap-27 Interested providers are invited to express their interest in this opportunity and provide feedback on the proposed procurement approach by responding to this notice using the contact details provided. BFT particularly welcomes feedback on the proposed procurement route, timeline and any other relevant considerations that may assist in informing the development of the procurement strategy. Organisations interested in this and future opportunities with the Trust are encouraged to register, free of charge, on the SAP Business Network Discovery Portal: SAP Business Network Discovery (ariba.com). This notice is issued for preliminary market engagement purposes only. It does not constitute a call for competition, commence a formal procurement process, or commit BFT to undertake a procurement exercise or award a contract. Any future procurement opportunity will be advertised separately in accordance with the applicable requirements of the Provider Selection Regime. The Trust will review and consider all feedback submitted but reserves the right to amend the structure, scope and procurement strategy described within this Notice prior to issuing the formal tender.

Gamma Irradiation of NHSBT Tissue Allografts and Consumables NHS Blood and Transplant (NHSBT) is looking to appoint a suitable supplier to provide gamma irradiation services for tissue allografts and consumables used by NHSBT Tissue and Eye Services (TES). NHSBT wishes to engage with suppliers before commencing a formal procurement process. The purpose of this engagement is to improve NHSBT’s understanding of current market capability, capacity, service delivery options and supplier interest in this requirement. The successful Supplier will be required to provide gamma irradiation of tissue products to an absorbed dose specification of 25kGy minimum and 40kGy maximum, and consumables to an absorbed dose specification of 25kGy minimum and 45kGy maximum. The Supplier must be able to process a range of tissue products and consumables, provide suitable frozen storage at approximately -20°C where required, maintain appropriate temperature records and return irradiated products within a maximum turnaround time of 72 hours. The Supplier must provide an irradiation certificate before products are released back to NHSBT. The certificate must include the minimum and maximum absorbed dose, routine dose, irradiation batch number and the relevant NHSBT product batch number. The Supplier will also be required to support dose mapping and performance qualification activities, undertake compatibility trials for new materials where required, operate an appropriate quality management system and maintain suitable validation, calibration, recall and business continuity arrangements. NHSBT intends to hold preliminary market engagement meetings. Meetings are expected to be held remotely, with final dates and times to be confirmed. To enable NHSBT to finalise the arrangements, interested organisations should send an expression of interest by email to Sahithi Bandi [email protected] no later than November 13th 2026.The response should include the organization’s name, proposed attendees and a brief overview, or website link, describing the relevant services available. Participation in this market engagement does not guarantee any future business. NHSBT is not committed to undertaking a procurement exercise or awarding a contract as a result of this notice. NHSBT will not reimburse suppliers for any costs incurred in participating in this engagement.

NHS Blood and Transplant is seeking to appoint a suitably qualified and experienced supplier to provide Qualified Person services in support of its portfolio of Investigational Medicinal Product manufacturing projects. The proposed service may include: reviewing and providing regulatory and quality input into selected regulatory submissions; advising on applicable regulatory, Good Manufacturing Practice and quality-compliance requirements for biological and Advanced Therapy Medicinal Product manufacturing projects; providing regulatory, GMP and quality input into the design and development of selected manufacturing processes and facilities; reviewing assigned batches and, where all applicable legal, regulatory, GMP, Clinical Trial Authorisation, Product Specification File and NHSBT quality-system requirements have been met, certifying batches for use in approved clinical trials; mentoring selected NHSBT staff undertaking the process of obtaining Qualified Person registration; and providing associated professional, regulatory and quality advice as required. Each Qualified Person proposed by the supplier will be expected to hold and maintain the qualifications, professional eligibility and regulatory status required to act as a Qualified Person for Investigational Medicinal Products in the UK. Proposed personnel should have recent and demonstrable experience of acting as a named Qualified Person on a UK Manufacturing and Import Authorisation for Investigational Medicinal Products, MIA(IMP), and of certifying IMP batches. Experience relating to biological, biotechnology, cell therapy and gene therapy medicinal products may also be required. The current anticipated level of support is approximately 24 to 48 days per year, with at least 50% of the support delivered on NHSBT premises and the remaining support delivered remotely, subject to agreement. The scope and requirements described in this notice are indicative and may be refined following preliminary market engagement.

Funeral Director Transportation Services within the North West of England for NHS Blood and Transplant

The Trust is undertaking a pre-market engagement exercise to gain a better understanding of the current market for tympanic thermometers and associated disposable probe covers. The information gathered will help inform the development of the procurement strategy, specification, evaluation criteria and overall requirement. This engagement does not constitute a commitment to commence a procurement process and is intended solely to gather market intelligence and supplier feedback. The Trust is interested in understanding the range of tympanic thermometer solutions currently available, including device functionality, clinical performance, technological developments and options for deployment across a variety of healthcare settings, including inpatient wards, outpatient departments, emergency care areas and theatre services. Through this pre-market engagement, the Trust aims to develop a comprehensive understanding of the available market solutions, supplier capabilities, emerging innovations and potential procurement options in order to inform the future procurement of tympanic thermometers and associated probe covers. The Trust will contact all suppliers who participated once the pre‑market engagement has closed, to arrange a supplier feedback meeting. We expect these meetings to take place before 11 December 2026.

Provision of medical physics advisory and quality assurance services to The Great Western Hospitals NHS Foundation Trust in relation to the use of all types of radiation throughout the Trust.

WorkWell is a national service commissioned across England by local Integrated Care Boards. It is an early-intervention work and health coaching and support service for people whose mental or physical health makes work a struggle. It offers light-touch, holistic, personalised coaching and support which is designed to prevent people from falling out of work because of health (or help them back quickly, before they become entrenched in health-related economic inactivity). Cornwall & Isles of Scilly, acting also on behalf of Devon ICB, wishes to contract the hub service strand of WorkWell in the SW peninsula region, which will employ a core coaching team providing coaching and support to participants across the whole of the Cornwall, Devon & Isles of Scilly peninsula for the period April 2027 to March 2031.